BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31605822)

  • 1. Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life.
    Georges GE; Bar M; Onstad L; Yi JC; Shadman M; Flowers ME; Carpenter PA; Stewart S; Lee SJ; Holmberg LA
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):407-412. PubMed ID: 31605822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
    Jandial A; Lad D; Jain A; Khadwal A; Singh C; Prakash G; Suri V; Sreedharanunni S; Sachdeva MUS; Ray P; Varma N; Varma S; Malhotra P
    Transpl Infect Dis; 2023 Oct; 25(5):e14123. PubMed ID: 37573150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
    D'Souza A; Brazauskas R; Stadtmauer EA; Pasquini MC; Hari P; Bashey A; Callander N; Devine S; Efebera Y; Ganguly S; Gasparetto C; Geller N; Horowitz MM; Koreth J; Landau H; Brunstein C; McCarthy P; Qazilbash MH; Giralt S; Krishnan A; Flynn KE
    Am J Hematol; 2023 Jan; 98(1):140-147. PubMed ID: 35567778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
    Chakraborty R; Yi J; Rybicki L; Preussler J; Deol A; Loren A; Savani B; Jim HSL; Cerny J; Reynolds J; Whitten J; Wingard JR; McGuirk JP; Uberti J; Khera N; Stiff P; Jaglowski SM; Hashmi S; Holtan SG; Devine S; Hahn T; Whalen VL; Saber W; Wood W; Baker KS; Syrjala K; Majhail NS
    Transplant Cell Ther; 2023 Jun; 29(6):388.e1-388.e6. PubMed ID: 36870388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation.
    Hegerova L; Bachan A; Cao Q; Vu HX; Rogosheske J; Reding MT; Brunstein CG; Arora M; Ustun C; Vercellotti GM; Bachanova V
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):e20-e25. PubMed ID: 30053647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.
    Kumar SK; Dispenzieri A; Fraser R; Mingwei F; Akpek G; Cornell R; Kharfan-Dabaja M; Freytes C; Hashmi S; Hildebrandt G; Holmberg L; Kyle R; Lazarus H; Lee C; Mikhael J; Nishihori T; Tay J; Usmani S; Vesole D; Vij R; Wirk B; Krishnan A; Gasparetto C; Mark T; Nieto Y; Hari P; D'Souza A
    Leukemia; 2018 Apr; 32(4):986-995. PubMed ID: 29263438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age.
    Dhakal B; Nelson A; Guru Murthy GS; Fraser R; Eastwood D; Hamadani M; Pasquini M; D'Souza A; Hari P
    Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):165-172. PubMed ID: 28159578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.
    Auner HW; Garderet L; Kröger N
    Br J Haematol; 2015 Nov; 171(4):453-62. PubMed ID: 26213240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early infectious complications after autologous hematopoietic cell transplantation for multiple myeloma.
    Rahman S; Rybicki L; Ky Hamilton B; Pohlman B; Jagadeesh D; Cober E; Kalaycio M; Dean R; Sobecks R; Mossad SB; Majhail NS
    Transpl Infect Dis; 2019 Aug; 21(4):e13114. PubMed ID: 31102556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
    Munshi PN; Vesole D; Jurczyszyn A; Zaucha JM; St Martin A; Davila O; Agrawal V; Badawy SM; Battiwalla M; Chhabra S; Copelan E; Kharfan-Dabaja MA; Farhadfar N; Ganguly S; Hashmi S; Krem MM; Lazarus HM; Malek E; Meehan K; Murthy HS; Nishihori T; Olin RL; Olsson RF; Schriber J; Seo S; Shah G; Solh M; Tay J; Kumar S; Qazilbash MH; Shah N; Hari PN; D'Souza A
    Cancer; 2020 Dec; 126(23):5077-5087. PubMed ID: 32965680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma.
    Savani M; Gencturk M; Shanley R; Cayci Z; Wilke C; Warlick ED; He F; Janakiram M; Weisdorf DJ; Brunstein CG; Bachanova V
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):272-277. PubMed ID: 31669174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
    Hong S; Rybicki L; Abounader D; Bolwell BJ; Dean R; Gerds AT; Hamilton BK; Hill BT; Jagadeesh D; Kalaycio M; Liu HD; Pohlman B; Sobecks R; Majhail NS
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1141-1144. PubMed ID: 26995694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?
    Kaya AH; Tekgunduz E; Akpinar S; Batgi H; Bekdemir F; Kayikci O; Namdaroglu S; Ulu BU; Dal MS; Cakar MK; Korkmaz S; Altuntas F
    Transplant Proc; 2017 Oct; 49(8):1911-1915. PubMed ID: 28923647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.
    Yeshurun M; Vaxman I; Shargian L; Yahav D; Bishara J; Pasvolsky O; Wolach O; Lahav M; Gurion R; Magen H; Vidal L; Herscovici C; Peck A; Moshe M; Sela-Navon M; Naparstek E; Raanani P; Rozovski U
    Clin Microbiol Infect; 2018 Jul; 24(7):749-754. PubMed ID: 29208561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older patients with myeloma derive similar benefit from autologous transplantation.
    Sharma M; Zhang MJ; Zhong X; Abidi MH; Akpek G; Bacher U; Callander NS; Dispenzieri A; Freytes CO; Fung HC; Gale RP; Gasparetto C; Gibson J; Holmberg LA; Kindwall-Keller TL; Klumpp TR; Krishnan AY; Landau HJ; Lazarus HM; Lonial S; Maiolino A; Marks DI; Mehta P; Mikhael Med JR; Nishihori T; Olsson R; Ramanathan M; Roy V; Savani BN; Schouten HC; Scott E; Tay J; To LB; Vesole DH; Vogl DT; Hari P
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1796-803. PubMed ID: 25046833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological Response to Vaccination after Autologous Transplantation for Multiple Myeloma Is Associated with Improved Progression-Free and Overall Survival.
    Merz AMA; Merz M; Zhang Y; Stecklein K; Pleskow J; Chen GL; Buck DA; Mohammadpour H; Herr MM; Elshoury A; Hillengass J; McCarthy PL; Hahn T
    Transplant Cell Ther; 2021 Mar; 27(3):245.e1-245.e8. PubMed ID: 34706824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Proliferating Regulatory T Cells Post-Transplantation Are Associated with Poor Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation.
    Sumransub N; Cao Q; Wangen R; Brunstein C; Miller JS; Bachanova V
    Transplant Cell Ther; 2022 Apr; 28(4):184.e1-184.e8. PubMed ID: 35081473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.
    Lemieux C; Ahmad I; Bambace NM; Bernard L; Cohen S; Delisle JS; Fleury I; Kiss T; Mollica L; Roy DC; Sauvageau G; Roy J; Lachance S
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):157-161. PubMed ID: 31521818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies.
    Ullrich CK; Baker KK; Carpenter PA; Flowers ME; Gooley T; Stevens S; Krakow EF; Oshima MU; Salit RB; Vo P; Connelly-Smith L; Lee SJ; Wood WA
    Transplant Cell Ther; 2023 Mar; 29(3):200.e1-200.e8. PubMed ID: 36494015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.